id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2023-N-0795-0009,FDA,FDA-2023-N-0795,Agency Information Collection Activities; Announcement of Office of Management and Budget Approval; Survey on Quantitative Claims in Direct-to-Consumer Prescription Drug Advertising,Notice,Notice of Approval,2024-07-23T04:00:00Z,2024,7,,,2024-07-23T13:27:31Z,2024-16096,0,0,09000064866021e5